Status:

RECRUITING

Smart Monitoring Assessing Spasticity-related Health

Lead Sponsor:

Heinrich-Heine University, Duesseldorf

Conditions:

Multiple Sclerosis

Eligibility:

All Genders

18+ years

Brief Summary

This observational study seeks to investigate the underlying of spasticity in patients with multiple sclerosis (MS) by employing multimodal monitoring techniques. By integrating digital biomarkers alo...

Detailed Description

The symptomatic treatment of spasticity in patients with multiple sclerosis (MS) is a major challenge for both patients and healthcare providers. However, monitoring and measuring the success or failu...

Eligibility Criteria

Inclusion

  • Patients must meet all the following criteria to be eligible to participate in the study:
  • ≥ 18 years of age
  • Diagnosis of multiple sclerosis according to the McDonald criteria of 2017
  • Presence of spasticity that requires medical treatment from a medical point of view
  • own and use a smartphone with Android 8.1 (or higher version) or iOS 12.3 (or higher version)
  • Able to operate a smartphone

Exclusion

  • Missing informed consent
  • Lack of declaration of consent
  • Unwillingness or inability to use the smartphone app
  • Any comorbidity that leads to impaired understanding or successful completion of the study, such as (but not limited to) psychiatric comorbidities or dementia. The decision will be made at the discretion of the investigators.

Key Trial Info

Start Date :

October 19 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

September 1 2025

Estimated Enrollment :

46 Patients enrolled

Trial Details

Trial ID

NCT06937723

Start Date

October 19 2023

End Date

September 1 2025

Last Update

April 22 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Medical Faculty, Heinrich-Heine-University

Düsseldorf, North Rhine-Westphalia, Germany, 40225

Smart Monitoring Assessing Spasticity-related Health | DecenTrialz